Benitec Biopharma Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 02/17/2026 | 11.55 M | $155.56 M | 16.93% | 25.12% |
| JANUS HENDERSON GROUP PLC | 02/17/2026 | 2.91 M | $39.29 M | 0.00% | 7.01% |
| FRANKLIN RESOURCES INC | 02/11/2026 | 2.20 M | $29.60 M | -15.15% | 5.29% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/17/2026 | 2.12 M | $28.57 M | 7.51% | 4.61% |
| RA CAPITAL MANAGEMENT, L.P. | 02/17/2026 | 1.85 M | $24.92 M | 100.00% | 4.02% |
| VANGUARD GROUP INC | 01/29/2026 | 1.17 M | $15.82 M | 18.41% | 2.56% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 02/13/2026 | 1.04 M | $13.99 M | 23.90% | 2.50% |
| INFINITUM ASSET MANAGEMENT, LLC | 02/17/2026 | 898.87 K | $12.11 M | 79.77% | 2.16% |
| BLACKROCK, INC. | 02/12/2026 | 992.35 K | $13.37 M | 4.95% | 2.16% |
| SIREN, L.L.C. | 02/13/2026 | 775.00 K | $10.44 M | 100.00% | 1.87% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 02/12/2026 | 731.72 K | $9.86 M | 164.86% | 1.76% |
| ALYESKA INVESTMENT GROUP, L.P. | 02/13/2026 | 750.00 K | $10.10 M | 100.00% | 1.63% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/17/2026 | 651.56 K | $8.78 M | 100.00% | 1.57% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 613.16 K | $8.26 M | 100.00% | 1.33% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 453.38 K | $6.11 M | 3.39% | 0.99% |
| AWM INVESTMENT COMPANY, INC. | 02/13/2026 | 282.98 K | $3.81 M | 54.65% | 0.68% |
| AMERIPRISE FINANCIAL INC | 02/17/2026 | 280.73 K | $3.78 M | 81.80% | 0.68% |
| SCHONFELD STRATEGIC ADVISORS LLC | 02/17/2026 | 262.21 K | $3.53 M | 0.69% | 0.63% |
| LONGAEVA PARTNERS L.P. | 02/17/2026 | 290.00 K | $3.91 M | 672.57% | 0.63% |
| STATE STREET CORP | 02/13/2026 | 245.05 K | $3.30 M | 12.20% | 0.53% |
| MYDA ADVISORS LLC | 02/13/2026 | 225.00 K | $3.03 M | 221.43% | 0.49% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 174.04 K | $2.34 M | -10.46% | 0.38% |
| SIMPLIFY ASSET MANAGEMENT INC. | 02/09/2026 | 151.16 K | $2.04 M | 92.01% | 0.36% |
| BURKEHILL GLOBAL MANAGEMENT, LP | 02/17/2026 | 150.00 K | $2.02 M | 100.00% | 0.33% |
| NORTHERN TRUST CORP | 02/17/2026 | 126.16 K | $1.70 M | -3.41% | 0.30% |
| WOODLINE PARTNERS LP | 02/17/2026 | 100.70 K | $1.36 M | 100.00% | 0.22% |
| UBS GROUP AG | 01/29/2026 | 98.35 K | $1.32 M | -1.59% | 0.21% |
| LION POINT CAPITAL, LP | 02/17/2026 | 62.00 K | $835.14 K | 0.00% | 0.15% |
| MORGAN STANLEY | 02/13/2026 | 58.81 K | $792.20 K | 264.91% | 0.13% |
| EMPERY ASSET MANAGEMENT, LP | 02/11/2026 | 55.44 K | $746.78 K | 100.00% | 0.12% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 45.27 K | $609.84 K | 0.00% | 0.11% |
| MARSHALL WACE, LLP | 02/13/2026 | 35.69 K | $480.72 K | 100.00% | 0.08% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 31.61 K | $425.81 K | -7.03% | 0.08% |
| QUADRATURE CAPITAL LTD | 02/17/2026 | 31.48 K | $424.05 K | 100.00% | 0.07% |
| BARCLAYS PLC | 02/13/2026 | 23.21 K | $312.65 K | 9.06% | 0.05% |
| PERSISTENT ASSET PARTNERS LTD | 02/17/2026 | 20.75 K | $279.54 K | 100.00% | 0.05% |
| NUVEEN, LLC | 02/12/2026 | 18.78 K | $252.95 K | 0.00% | 0.04% |
| RHUMBLINE ADVISERS | 02/13/2026 | 17.67 K | $237.98 K | -13.92% | 0.04% |
| CITADEL ADVISORS LLC | 02/17/2026 | 17.58 K | $236.80 K | 100.00% | 0.04% |
| SQUAREPOINT OPS LLC | 02/13/2026 | 15.05 K | $202.66 K | 100.00% | 0.04% |
| WELLS FARGO & COMPANY/MN | 02/13/2026 | 16.26 K | $219.05 K | 78.06% | 0.04% |
| DEUTSCHE BANK AG\ | 02/11/2026 | 12.31 K | $165.78 K | -26.50% | 0.03% |
| HRT FINANCIAL LP | 02/12/2026 | 13.29 K | $178.00 K | 100.00% | 0.03% |
| JANE STREET GROUP, LLC | 02/12/2026 | 12.43 K | $167.37 K | 100.00% | 0.03% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 12.13 K | $163.32 K | 60.38% | 0.03% |
| METLIFE INVESTMENT MANAGEMENT, LLC | 02/12/2026 | 9.40 K | $126.58 K | 0.00% | 0.02% |
| SG AMERICAS SECURITIES, LLC | 01/09/2026 | 8.23 K | $111.00 K | 100.00% | 0.02% |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 02/17/2026 | 6.90 K | $92.97 K | 1.75% | 0.02% |
| RUSSELL INVESTMENTS GROUP, LTD. | 02/17/2026 | 6.22 K | $83.76 K | 10.74% | 0.02% |
| GAMMA INVESTING LLC | 01/05/2026 | 6.73 K | $90.59 K | -0.01% | 0.01% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Benitec Biopharma Inc institutional Ownership - FAQ's
During the previous two years, 88 institutional investors and hedge funds held shares of Benitec Biopharma Inc. The most heavily invested institutionals were:
Simplify Asset Management Inc.: 562,242
VANGUARD FIDUCIARY TRUST CO: 171,753
Russell Investments Group, Ltd.: 116,190
UBS Group AG: 115,819
Bank of New York Mellon Corp: 43,489
Nuveen, LLC: 41,814
68.87% of Benitec Biopharma Inc stock is owned by institutional investors.
Institutional investors have bought a total of 32.45 M shares in the last 24 months. This purchase volume represents approximately $407.27 M in transactions.